[1]MAHY B W J.Introduction and history of foot‑and‑mouth disease virus[J].Current Topics in Microbiology and Immunology,2005,288:1‑8.
[2]KNIGHT‑JONES T J D,ROBINSON L,CHARLESTON B,et al.Global foot‑and‑mouth disease research update and gap analysis:2‑epidemiology,wildlife and economics[J].Transboundary and Emerging Diseases,2016,63(S1):14‑29.
[3]沈超,曾一歌.口蹄疫病毒持续感染的研究进展[J].华中师范大学学报(自然科学版),2022,56(4):662‑669.
SHEN C,ZENG Y G.Research progress in persistent infection of foot‑and‑mouth disease virus[J].Journal of Central China Normal University(Natural Sciences),2022,56(4):662‑669.
[4]GAO H Y,MA J.Spatial distribution and risk areas of foot and mouth disease in mainland China[J].Preventive Veterinary Medicine,2021,189:105311.
[5]LI X Y,WANG J C,LIU J,et al.Engagement of soluble resistance‑related calcium binding protein(sorcin)with foot‑and‑mouth disease virus(FMDV)VP1 inhibits type I interferon response in cells[J].Veterinary Microbiology,2013,166(1/2):35‑46.
[6]LI D,YANG W P,YANG F,et al.The VP3 structural protein of foot‑and‑mouth disease virus inhibits the IFN‑β signaling pathway[J].FASEB Journal,2016,30 (5):1757‑1766.
[7]LI D,WEI J,YANG F,et al.Foot‑and‑mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN‑γ signal transduction pathways[J].Cell Cycle,2016,15(6):850‑860.
[8]DE LOS SANTOS T,DE AVILA BOTTON S,WEIBLEN R,et al.The leader proteinase of foot‑and‑mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response[J].Journal of Virology,2006,80(4):1906‑1914.
[9]WANG D,FANG L R,LI P,et al.The leader proteinase of foot‑and‑mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase[J].Journal of Virology,2011,85(8):3758‑3766.
[10]GLADUE D P,LARGO E,DE LA ARADA I,et al. Molecular characterization of the viroporin function of foot‑and‑mouth disease virus nonstructural protein 2B [J].Journal of Virology, 2018, 92 (23) :e01360‑e01318.
[11]LI M,XIN T,GAO X T,et al.Foot‑and‑mouth disease virus non‑structural protein 2B negatively regulates the RLR‑mediated IFN‑β induction[J].Biochemical and Biophysical Research Communications,2018,504(1):238‑244.
[12]GUO Z J, ZHAO Y, ZHANG Z D, et al. Interleukin‑10‑mediated lymphopenia caused by acute infection with foot‑and‑mouth disease virus in mice[J].Viruses,2021,13(12):2358.
[13]YUE F,CHENG A C,ZHU Y P,et al.Overexpression of programmed death ligands in naturally occurring postweaning multisystemic wasting syndrome[J].Viral Immunology,2015,28(2):101‑106.
[14]岳锋,朱艳平,银梅,等.猪瘟病毒TaqMan实时荧光定量PCR检测方法的建立及初步应用[J].中国畜牧兽医,2014,41(6):18‑22.
YUE F,ZHU Y P,YIN M,et al.Development and application of TaqMan fluorescence quantitative PCR assay for detecting classical swine fever virus[J].China Animal Husbandry & Veterinary Medicine,2014,41(6):18‑22.
[15]MOLINA G N,CACCIABUE M,GISMONDI M I,et al.Baculovirus AcMNPV induces type I interferons and NK/NKT cells‑mediated protection against foot‑and‑mouth disease virus in mice[J].Antiviral Research,2020,180:104850.
[16]DÍAZ‑SAN SEGUNDO F,RODRÍGUEZ‑CALVO T,DE AVILA A,et al.Immunosuppression during acute infection with foot‑and‑mouth disease virus in swine is mediated by IL‑10[J].PLoS One,2009,4(5):e5659.
[17]CHUA C,SALIMZADEH L,MA A T,et al.IL‑2 produced by HBV‑specific T cells as a biomarker of viral control and predictor of response to PD‑1 therapy across clinical phases of chronic hepatitis B[J].Hepatology Communications,2023,7(12):e0337.
[18]CHEN R Y,ZHU Y,SHEN Y Y,et al.The role of PD‑1 signaling in health and immune‑related diseases[J].Frontiers in Immunology,2023,14:1163633.
[19]PEÑA‑ASENSIO J,CALVO H,TORRALBA M,et al.Gamma‑chain receptor cytokines & PD‑1 manipulation to restore HCV‑specific CD8+ T cell response during chronic hepatitis C[J].Cells,2021,10(3):538.
[20]RICHTER K,PERRIARD G,OXENIUS A.Reversal of chronic to resolved infection by IL‑10 blockade is LCMV strain dependent[J].European Journal of Immunology,2013,43(3):649‑654.
|